Jeff Landau
2023
In 2023, Jeff Landau earned a total compensation of $1M as Senior Vice President and Chief Business Officer at CytomX Therapeutics, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Option Awards | $169,270 |
| Salary | $415,692 |
| Stock Awards | $297,850 |
| Other | $5,000 |
| Total | $1,047,812 |
Landau received $415.7K in salary, accounting for 40% of the total pay in 2023.
Landau also received $160K in non-equity incentive plan, $169.3K in option awards, $297.9K in stock awards and $5K in other compensation.
Rankings
In 2023, Jeff Landau's compensation ranked 1,159th out of 3,006 executives tracked by ExecPay. In other words, Landau earned more than 61.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,159 out of 3,006 | 61st |
Division Manufacturing | 693 out of 1,650 | 58th |
Major group Chemicals And Allied Products | 463 out of 918 | 50th |
Industry group Drugs | 452 out of 881 | 49th |
Industry Pharmaceutical Preparations | 312 out of 637 | 51st |
Source: SEC filing on April 4, 2024.
Landau's colleagues
We found two more compensation records of executives who worked with Jeff Landau at CytomX Therapeutics in 2023.